Skip to main content
915 TLDR
Health
1 read

Eczema Treatment Cream Recalled Due to Serious Infection Risk

KTSMJeremy Tanner
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

A recall has been issued for the Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, marketed as MG217, after contamination with Staphylococcus aureus was detected. This bacteria poses a significant risk of life-threatening infections, prompting the Food and Drug Administration (FDA) to take action. Consumers using this product should be aware of the potential health hazards associated with it. The recall affects a specific batch of the cream, and users are advised to discontinue its use immediately and consult healthcare professionals if they experience any adverse effects.

Key Details: • Discontinue use of MG217 Eczema Cream immediately. • Consult a healthcare provider if experiencing any symptoms of infection. • Check product packaging for batch numbers related to the recall.

health fda recall eczema staph-infection

People & Organizations

WisconsinFood and Drug AdministrationPharmacal

Related Articles